Senior Scientist, Antibody Conjugation

BioSpace

Brisbane (CA)

On-site

USD 175,000 - 185,000

Full time

2 days ago
Be an early applicant
Application generator

Stand out for this role — generate a tailored resume and cover letter in about a minute.

Get past ATS filters

Benefits offered by this job

Bonus
Equity

Job summary

Nurix is seeking a Senior Scientist, Antibody Conjugation to build and own a new bioconjugation capability. You will develop robust chemistries, transfer workflows to automation, and scale conjugation for in vivo studies.

You will partner with medicinal chemistry, analytical chemistry, computational chemistry, protein biochemistry, and automation teams to move candidates from bench to study-ready material. You will lead method development, protocol transfer to liquid-handling platforms, and

Qualifications

  • PhD or equivalent with hands-on bioconjugation experience preferred.
  • ,
  • ],
  • job_responsibilities_description":[

Responsibilities

  • Develop and optimize antibody bioconjugation methods for degrading payloads and linkers.

Skills

Antibody bioconjugation chemistry
FPLC/AKTA purification
TFF/SEC/IEX/RP-HPLC/UPLC/HIC/LC-MS DAR
Automation-ready protocols
NHS ester/maleimide coupling
CuAAC/SPAAC/IEDDA
Site-specific conjugation (engineered‑
Unnatural amino acids conjugation

Education

PhD in chemistry/biochemistry/chemical biology or related field
MS/BS with hands-on industry bioconjugation experience

Tools

Hamilton liquid handler
Tecan liquid handling system

Job description

Senior Scientist, Antibody Conjugation
About the Role

We are growing the team with a hands-on antibody conjugation scientist who will build this capability from the ground up by developing and validating bioconjugation chemistries that are reproducible at bench scale, sufficiently robust for transfer to automated higher-throughput synthesis workflows, and scalable for preparation campaigns supporting advanced in vivo and translational studies.

This is a lab-based role for someone who wants to build a new technical capability inside an established, highly collaborative discovery organization and partner closely with medicinal chemistry, analytical chemistry, computational chemistry, protein biochemistry, and automation to move candidates from bench to study-ready material.

What You'll Do
  • Develop and optimize antibody bioconjugation methods for attaching degrader payloads and linkers to antibodies.
  • Design conjugation chemistry with an eye toward automation: define protocols, reagent ratios, and process parameters in a form that can be transferred to and run reliably on liquid-handling platforms.
  • Execute one-off and scale-up conjugation runs (mg to multi-mg) to produce material for pharmacology, PK/PD, and other advanced studies on program timelines.
  • Purify conjugates via FPLC/AKTA, TFF, and column chromatography; troubleshoot yield, homogeneity, and stability issues as they arise.
  • Write clear SOPs and technical reports; train and support automation-team colleagues in executing conjugation workflows independently.
  • Collaborate cross-functionally with medicinal chemists (linker/payload design), computational chemists (site selection, modeling), and external CROs/CDMOs as needed.
  • Stay current on emerging bioconjugation and DAC/ADC methodology and bring forward new techniques relevant to Nurix's pipeline.
Who You Are
  • A team player who works well across disciplines (chemistry, analytical, protein biochemistry, automation/engineering) and communicates clearly with both scientists and technical staff.
  • Results-oriented: you drive a method from first attempt to a robust, transferable protocol, and you personally deliver material when a study needs it.
  • Comfortable owning a technical area with real autonomy in a growing capability area.
Qualifications
  • PhD in chemistry, biochemistry, chemical biology, or a related field preferred; MS or BS with substantial (8+ for BS/MS) hands‑on industry bioconjugation experience will also be considered.
  • Direct, hands‑on experience with antibody/protein bioconjugation chemistry: NHS ester and maleimide coupling, click chemistry (CuAAC/SPAAC/IEDDA), engineered‑cysteine or glycan/enzymatic site‑specific conjugation, or unnatural‑amino‑acid approaches.
  • Experience purifying and characterizing conjugates: FPLC/AKTA, TFF, SEC, IEX, RP‑HPLC/UPLC, HIC, and LC‑MS‑based DAR/identity analysis.
  • Experience preparing protocols for automated or semi‑automated execution (e.g., liquid handlers such as Hamilton or Tecan) is a strong plus, though the successful candidate may also learn this in partnership with our automation team.
  • Strong record of practical problem‑solving in the lab, with the judgment to know when a result is study‑ready versus needs more optimization.
Why This Role

You’ll be the founding technical expert for antibody conjugation at Nurix, shaping both the science and how it's automated and scaled — with direct visibility to program leadership and a fast path from method development to real studies.

Salary Range: $174,900 - $185,200 plus bonus and equity

Fit with Nurix Culture and Values
  • Strong team orientation; highly collaborative.
  • Solutions and results-oriented focus.
  • Hands‑on approach; resourceful and open to diverse points of view.

We are an Equal Opportunity Employer offering a competitive salary and benefits package. Applicants should be legally entitled to work for any employer in the US.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Senior Scientist, Antibody Conjugation
Senior Scientist, Antibody Conjugation

NURIX • Brisbane (CA)

On-site
USD 175,000 - 185,000
Senior Scientist, Antibody Conjugation Brisbane, CA
Senior Scientist, Antibody Conjugation Brisbane, CA

Nurix, Inc. • California (MO)

On-site
USD 155,000 - 180,000
Senior Scientist, Antibody Conjugation
Senior Scientist, Antibody Conjugation

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 155,000 - 180,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

Nurix Therapeutics • Brisbane (CA)

On-site
USD 140,000 - 161,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

NURIX • South San Francisco (CA)

On-site
USD 133,000 - 148,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

BioSpace • Brisbane (CA)

On-site
USD 140,000 - 161,000
Scientist II, Degrader Antibody Conjugate Characterization
Scientist II, Degrader Antibody Conjugate Characterization

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 140,000 - 161,000
Scientist II, Degrader Antibody Conjugate Characterization Brisbane, CA
Scientist II, Degrader Antibody Conjugate Characterization Brisbane, CA

Nurix, Inc. • California (MO)

On-site
USD 140,000 - 161,000
Senior Scientist, Antibody Conjugation — Automate & Scale
Senior Scientist, Antibody Conjugation — Automate & Scale

BioSpace • Brisbane (CA)

On-site
USD 175,000 - 185,000
Bonus
Equity
Senior Antibody Bioconjugation Scientist (Automation Ready)
Senior Antibody Bioconjugation Scientist (Automation Ready)

Initial Therapeutics, Inc. • Brisbane (CA)

On-site
USD 155,000 - 180,000